Alan C. Braverman, MD, FACC
Professor of Medicine; Alumni Endowed Professor of Cardiovascular Diseases; Director, Marfan Syndrome Clinic; Chief-of-Service, Inpatient Cardiology
- Phone: 314-362-1291
- Fax: 314-362-4619
- BA, Biology with Distinction: University of Missouri-Kansas City (1984)
- MD: University of Missouri-Kansas City School of Medicine (1985)
- Intern in Internal Medicine: Brigham and Women’s Hospital, Boston, Massachusetts (1985-1986)
- Resident in Internal Medicine: Brigham and Women’s Hospital, Boston, Massachusetts (1986-1988)
- Clinical Fellow in Medicine: Harvard Medical School, Boston, Massachusetts (1985-1989)
- Fellow in Cardiology: Brigham and Women’s Hospital, Boston, Massachusetts (1988-1990)
- Chief Medical Resident: Brigham and Women’s Hospital, Boston, Massachusetts (1990-1991)
- Research Fellow in Medicine: Harvard Medical School, Boston, Massachusetts (1989-1990)
- Cardiovascular Disease
- Internal Medicine
- Benico Barzilai Award, 2016
- Inductee, Academic Hall of Fame, inaugural class, Smith Cotton High School, Sedalia, MO, 2013
- US News “Top Doctors in America,” US News and World Report and Castle Connelly, Ltc, Top 1% of doctors in USA in specialty, 2013
- “Alan Braverman Fund,” Creation of a fund within the National Marfan Foundation in honor of Dr. Alan Braverman awarded at Heartworks St Louis Gala, 2013
- Internal Medicine Attending of the Month Award, Barnes-Jewish Hospital and Washington University School of Medicine, Perion I, 2012
- US News “Top Doctors in America” US News and World Report and Castle Connelly, Ltc, Top 1% of doctors in USA in specialty, 2012
I am a Professor of Medicine in the Cardiovascular Division of the Department of Medicine at Washington University School of Medicine. I specialize in Clinical Cardiology. I have a busy clinical practice and have interests in all aspects of non-invasive cardiology including preventive cardiology, valvular heart disease, heart failure, hypertension, hyperlipidemia, arrhythmias and coronary artery disease. I have a special interest and expertise in genetically triggered aortic diseases, such as Marfan syndrome and related disorders, Loeys-Dietz aneurysm syndrome, Familial Thoracic Aortic aneurysm/dissection, thoracic aortic aneurysms and dissections and bicuspid aortic valve disease. I serve as Director of the Marfan Syndrome Clinic at Washington University School of Medicine and Barnes-Jewish Hospital. In this multidisciplinary clinic, myself and Dr. Alison Whelan (medical geneticist), evaluate adult patients and families with suspected Marfan syndrome and related disorders. I also see patients as part of the Center for Thoracic Aortic Diseases. I am proud to serve on the Professional Advisory Board of the National Marfan Foundation.
I also have a strong interest in teaching our medical students, house officers and fellows. I serve as Director of the Inpatient Cardiology Service.
I am interested in Genetically Triggered Thoracic Aortic Aneurysm syndromes. These include Marfan syndrome, Loeys-Dietz aneurysm syndrome, bicuspid aortic valve disease (including bicuspid aortic valve aortopathy), thoracic aortic aneurysms/dissections, FTAA-D syndromes and aortic dissection. I direct the Marfan Syndrome Clinic at Barnes-Jewish Hospital and Washington University. This clinic has grown into one of the largest multidisciplinary clinics with expertise in caring for people and families with Marfan syndrome and related disorders.
I participate in several multicenter databases and registries as well as clinical trials involving patients with aortic disease, including being the site PI for the International Registry of Aortic Dissection (IRAD) at Washington University. Along with Dr. Marc Moon, I am a participant for our clinical site in the long term outcomes study , “Aortic Valve Operative Outcomes in Marfan Patients,” A Multicenter, International Registry of Aortic Surgery Outcomes in Patients with Marfan Syndrome, sponsored by the National Marfan Foundation.
Also, I serve as Co-Principal Investigator, Trial of Beta Blocker Therapy (Atenolol) vs. Angiotensin II Receptor Blocker Therapy (Losartan) in Individuals with Marfan Syndrome. This is a National Heart Lung Blood Institute and Pediatric Heart Network sponsored international trial. I am involved in enrolling the adults for this trial at Washington University , School of Medicine and Barnes-Jewish Hospital . Dr. Angela Sharkey from St. Louis Children’s Hospital serves as PI on this study from our site and enrolls the children for this trial.